Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPHERE: Stroke Prevention With Hydroxyurea in Children With Sickle Cell Anaemia
NCT03948867Phase 2Active, not recruiting
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Apr 2019
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of hydroxyurea in sickle cell anemia (SCA), sponsored by Cincinnati Children's Hospital Medical Center. Started Apr 2019; status: active, not recruiting.
02
Drugs
hydroxyurea
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT03948867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03948867.